Nasal Swab Home Collection Kit (NSHC Kit) Study
NCT03813966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1181
Last updated 2020-10-05
Summary
The purpose of this study is to demonstrate that persons over the age of 13 years can obtain a self-collected nasal swab reliably and safely for subsequent use in the diagnosis of influenza. Similarly, the purpose is to demonstrate that parents or guardians can safely and effectively collect nasal swab specimens from children, ages 0 through 12 years, and others needing assistance in doing so, and that these parent/guardian-collected nasal swabs can also be used in the diagnosis of influenza. Clinical performance of the swabs will be based on the comparison of the performance of the nasal swab that is self- or parent/guardian-collected to one collected from the same specimen donor by a skilled clinical coordinator and used in CLIA (Clinical Laboratory Improvement Amendments)-waived, rapid diagnostic test called Sofia Influenza A+B FIA (fluorescence immunoassay analyzer).
Conditions
- Influenza Viral Infections
Interventions
- DIAGNOSTIC_TEST
-
Sofia Influenza A+B FIA
The Nasal Swab Home Collection Kit (NSHC Kit) provides the materials and training needed for you to safely collect a nasal swab at home. The sample can then be delivered to a designated test site for influenza testing.
Sponsors & Collaborators
-
Quidel Corporation
collaborator INDUSTRY -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Jonathan Temte, MD PhD · University of Wisconsin, Madison
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-07
- Primary Completion
- 2020-03-04
- Completion
- 2020-06-30
Countries
- United States
Study Locations
More Related Trials
-
Home Administration of FluMist by Parents/Caregivers
NCT01938170 ·Status: COMPLETED ·Phase: NA
-
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
NCT01309568 ·Status: COMPLETED
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)
NCT00783926 ·Status: COMPLETED ·Phase: PHASE1
-
Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines
NCT01086566 ·Status: COMPLETED ·Phase: PHASE1
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
NCT05050318 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects
NCT01313962 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults
NCT01776541 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine
NCT01098786 ·Status: COMPLETED
-
Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)
NCT00566345 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer
NCT01354379 ·Status: COMPLETED ·Phase: PHASE1
-
Covid Flu A/B and RSV 4 in 1 Diagnostic Test
NCT07308158 ·Status: COMPLETED
-
QuickVue Influenza A+B Clinical Field Trial
NCT00491283 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
NCT01992107 ·Status: COMPLETED ·Phase: PHASE3
-
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine
NCT00561002 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children
NCT01776554 ·Status: COMPLETED ·Phase: PHASE2
-
Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects
NCT00996138 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 1b Influenza Vaccine Study in Healthy Subjects
NCT01181336 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model
NCT05507567 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
NCT00800605 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
NCT01746082 ·Status: COMPLETED ·Phase: PHASE2